These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7603231)

  • 1. Direct measurement of nitric oxide in human beings.
    Vallance P; Patton S; Bhagat K; MacAllister R; Radomski M; Moncada S; Malinski T
    Lancet; 1995 Jul; 346(8968):153-4. PubMed ID: 7603231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
    Bedarida GV; Kim D; Blaschke TF; Hoffman BB
    Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo.
    Vallance P; Collier J; Moncada S
    Cardiovasc Res; 1989 Dec; 23(12):1053-7. PubMed ID: 2620324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
    Boulanger C; Schini VB; Moncada S; Vanhoutte PM
    Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor inhibits stimulated but not basal release of nitric oxide.
    Xie J; Wang Y; Lippton H; Cai B; Nelson S; Kolls J; Summer WR; Greenberg SS
    Am Rev Respir Dis; 1993 Sep; 148(3):627-36. PubMed ID: 7690209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDRF in pulmonary resistance vessels from fetal lamb: stimulation by oxygen and bradykinin.
    Wang Y; Coceani F
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H936-43. PubMed ID: 8160841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-derived and intraneuronal nitric oxide-dependent inhibition of norepinephrine efflux from sympathetic nerves by bradykinin.
    Greenberg SS; Peevy K; Tanaka TP
    Am J Hypertens; 1991 May; 4(5 Pt 1):464-7. PubMed ID: 2069780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries.
    Cogswell AM; Johnson PJ; Adams HR
    Am J Vet Res; 1995 Dec; 56(12):1637-41. PubMed ID: 8599526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
    Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
    J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide.
    Figini M; Ricciardolo FL; Javdan P; Nijkamp FP; Emanueli C; Pradelles P; Folkerts G; Geppetti P
    Am J Respir Crit Care Med; 1996 Mar; 153(3):918-23. PubMed ID: 8630573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation.
    Whittle BJ; Lopez-Belmonte J; Rees DD
    Br J Pharmacol; 1989 Oct; 98(2):646-52. PubMed ID: 2479442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
    Kato M; Shiode N; Teragawa H; Hirao H; Yamada T; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1999 May; 38(5):394-400. PubMed ID: 10397075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C; Leuschner S; Schwanebeck U; Kirch W
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide is the endothelium-derived relaxing factor in bovine pial arterioles.
    Fischer-Nakielski H; Schrör K
    Stroke; 1990 Dec; 21(12 Suppl):IV46-8. PubMed ID: 2124388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
    Gold ME; Wood KS; Byrns RE; Fukuto J; Ignarro LJ
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4430-4. PubMed ID: 2162040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective production of endothelium-derived nitric oxide in canine femoral veins.
    Miller VM
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H677-82. PubMed ID: 1679603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.
    Vallance P; Collier J; Moncada S
    Lancet; 1989 Oct; 2(8670):997-1000. PubMed ID: 2572793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidences for the existence of endothelium-derived relaxing factor in the renal medulla.
    Biondi ML; Dousa T; Vanhoutte P; Romero JC
    Am J Hypertens; 1990 Nov; 3(11):876-8. PubMed ID: 2175626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.